Oral antibiotics to prevent bile duct inflammation after Kasai surgery
Part of Digestive system, Genetic & congenital clinical trials.
This trial studies whether giving oral antibiotics before symptoms start can lower the chance of cholangitis (bile duct infection/inflammation) after Kasai portoenterostomy. It may help protect your child’s bile flow and reduce painful or serious infections after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child had Kasai portoenterostomy at Children’s Hospital of Fudan University
- The surgery age was between 14 and 90 days after birth
- Your child was born after 36 weeks of pregnancy and weighed over 2 kg before surgery
- The diagnosis is “type-III biliary atresia,” based on a scan or surgical findings
- Liver biopsy results are available, including specific microscope stain reports
- Your child is not allergic to the planned post-surgery medications and has not used other antibiotics or probiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to better define and treat bile duct infections (cholangitis) that can happen in the first year after Kasai surgery for biliary atresia. It aims to improve care for infants and children who have had this surgery.
This study tests whether giving umbilical cord stem cells during early Kasai surgery (a procedure to help drain bile) improves outcomes for infants with biliary atresia. It may help your baby's liver function and overall health.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.
This trial tests a new treatment using stem cells from umbilical cord blood or tissue, given to infants with biliary atresia during their Kasai surgery. The goal is to improve liver function and reduce the need for a liver transplant.
This early-phase study tests whether the antibiotic vancomycin can help children with primary sclerosing cholangitis or biliary atresia, and related gut/bile duct problems. It may work by changing gut bacteria, but you would need to avoid certain medicines beforehand.
Hear when a new Biliary Atresia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.